IRVINE, CA--(Marketwire - June 12, 2009) - Edwards Lifesciences Corporation (NYSE: EW), the
world leader in the science of heart valves, announced today that the
United Kingdom High Court of Justice has determined that Cook Inc.'s UK
transcatheter valve patent is invalid and not infringed by the Edwards
SAPIEN transcatheter valve.
"We are gratified that the UK court has found Cook's patent invalid and has
agreed with a German court decision that Edwards does not infringe the Cook
patent," said Larry L. Wood, Edwards' corporate vice president,
transcatheter valve replacement. "We remain committed to protecting our
comprehensive intellectual property in transcatheter heart valves, which
represents one important element of our broader leadership strategy."
As previously announced, the District Court of Düsseldorf, Germany,
determined in March 2009 that Edwards does not infringe Cook's German
patent. Edwards has a separate lawsuit claiming invalidity of Cook's
German transcatheter valve patent, which is expected to be heard in Munich
in 2010.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring, with more than five decades of experience in
partnering with clinicians to develop life-saving innovations.
Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular
disease with its market-leading heart valve therapies, and critical care
and vascular technologies, which are sold in approximately 100 countries.
The company's global brands include Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional
company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation; Edwards
Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards,
Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are
trademarks of Edwards Lifesciences Corporation and are registered in the
United States Patent and Trademark Office.
